Cargando…
The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes
Myelodysplastic syndromes (MDS) are hematopoietic stem cell (HSC) malignancies characterized by ineffective hematopoiesis, with increased incidence in older individuals. Here we analyze the transcriptome of human HSCs purified from young and older healthy adults, as well as MDS patients, identifying...
Ejemplares similares
-
Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution
por: Ainciburu, Marina, et al.
Publicado: (2023) -
Genome-wide analysis of the H3K27me3 epigenome and transcriptome in Brassica rapa
por: Payá-Milans, Miriam, et al.
Publicado: (2019) -
Characterization of freshly isolated bone marrow mesenchymal stromal cells from healthy donors and patients with multiple myeloma: transcriptional modulation of the microenvironment
por: Alameda, Daniel, et al.
Publicado: (2020) -
Dyserythropoiesis and myelodysplasia in thiamine‐responsive megaloblastic anemia syndrome
por: Faraji‐Goodarzi, Mojgan, et al.
Publicado: (2020) -
Images from the Haematologica Atlas of Hematologic Cytology: dyserythropoiesis
por: Invernizzi, Rosangela
Publicado: (2022)